Friday, November 4, 2016

Pharma Reviews: BSE Healthcare index dips by over 700 points on news of US probe

The US probe in respect of price collusion may adversely impact Indian pharma companies as significant portion of their revenues is coming from US ...
Read more: BSE Healthcare index dips by over 700 points on news of US probe